Abstract:We previously demonstrated that in Ifnar1 -/- Ifngr1 -/- or Stat1 -/- suckling mice lacking intact type I and type II interferon (IFN) signaling, rhesus rotavirus (RRV) infection causes a lethal disease with clinical manifestations similar to biliary atresia, including acholic stools, oily fur, growth retardation, and excess mortality. Elevated levels of viral RNA are detected in the bile ducts and liver of diseased pups together with severe inflammatory responses in these tissues. However, the viral determinants and the molecular mechanisms driving this process remain incompletely understood. Using an optimized rotavirus (RV) reverse genetics system, we generated a panel of recombinant RVs that encode non-structural protein 1 (NSP1) derived from different RV strains. We found that compared to the parental simian SA11 strain that is less biliary pathogenic, SA11 containing an RRV-derived NSP1 resulted in severe biliary obstructive disease comparable to that associated with RRV infection, reflected by high levels of viral RNA and inflammation in the biliary tract, liver, and pancreas. In contrast, RRV containing an SA11-originated NSP1 showed only mild biliary obstruction comparable to what was observed during SA11 infection. Infection with a monoreassortant RRV virus carrying NSP1 from the bovine RV UK strain also showed substantially reduced viral replication in extra-intestinal organs and did not develop clinical biliary diseases. Mechanistically, RRV NSP1 seemed to promote active viral replication in hepatocytes and this expanded tropism led to enhanced infiltration of CD4 and CD8 T cells, causing immunopathology and damage in the hepatobiliary system. These results highlight an unexpectedly important role of RV NSP1 in viral replication and disease progression in extra-intestinal tissues. In our research, we investigated how specific proteins from the rotavirus, a virus known for causing gastrointestinal infections, influence the severity of liver diseases in a special mouse model. We found that a protein called NSP1, which varies between different strains of the virus, plays a key role in how severe the liver disease becomes. Mice that lacked certain immune system components developed a serious liver condition similar to biliary atresia—a disease that affects the bile ducts and liver. When these mice were infected with a strain of rotavirus carrying NSP1 from another strain, they showed much more severe liver damage compared to those infected with a different strain. Our findings highlight the significant role of NSP1 in promoting viral replication in the liver and bile ducts. This research may help us understand whether and why some rotavirus strains cause more severe liver disease than others and could guide future studies aiming to develop better treatments for such infections. By uncovering these details, we aim to improve our understanding of rotavirus and its impact on the liver, potentially leading to better strategies for managing and treating related diseases.

Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells

Nlrp6 Regulates Intestinal Antiviral Innate Immunity

MyD88-mediated TLR signaling protects against acute rotavirus infection while inflammasome cytokines direct Ab response

TRIM29 controls enteric RNA virus-induced intestinal inflammation by targeting NLRP6 and NLRP9b signaling pathways

Sodium Butyrate Protects Against Rotavirus-Induced Intestinal Epithelial Barrier Damage by Activating AMPK-Nrf2 Signaling Pathway in IPEC-J2 Cells

Reverse Genetics Reveals a Role of Rotavirus VP3 Phosphodiesterase Activity in Inhibiting RNase L Signaling and Contributing to Intestinal Viral Replication In Vivo

Segmented Filamentous Bacteria Prevent and Cure Rotavirus Infection

Rotavirus nonstructural protein 1 antagonizes innate immune response by interacting with retinoic acid inducible gene I

NLRP9 involved in antiviral innate immunity via binding VIM in IPEC-J2 cells

NLRC5 deficiency has a moderate impact on immunodominant CD8+ T-cell responses during rotavirus infection of adult mice

Rotavirus VP3 Targets MAVS for Degradation to Inhibit Type III Interferon Expression in Intestinal Epithelial Cells.

DHX15 is required to control RNA virus-induced intestinal inflammation

Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus Infection

Regulation and functions of the NLRP3 inflammasome in RNA virus infection

Recognition of Double-Stranded RNA by TLR3 Induces Severe Small Intestinal Injury in Mice.

M6a Modifications Regulate Intestinal Immunity and Rotavirus Infection

NLRP1B allele 2 does not respond to Val-boro-Pro (VbP) in the intestinal epithelium

Activation of the NLRP1 Inflammasome and Its Role in Transmissible Gastroenteritis Coronavirus Infection

Rotavirus Interactions With Host Intestinal Epithelial Cells

Rhesus rotavirus NSP1 mediates extra-intestinal infection and is a contributing factor for biliary obstruction

TLR3/TRIF and MAVS Signaling Is Essential in Regulating Mucosal T Cell Responses during Rotavirus Infection